These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6379107)

  • 21. Protein A and staphylococcal products in neoplastic disease.
    Terman DS
    Crit Rev Oncol Hematol; 1985; 4(2):103-24. PubMed ID: 3905035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus.
    Gordon BR; Matus RE; Saal SD; MacEwen EG; Hurvitz AI; Stenzel KH; Rubin AL
    J Natl Cancer Inst; 1983 Jun; 70(6):1127-33. PubMed ID: 6343694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The initial experience of using extracorporeal plasmoimmunosorption with protein A in the combined treatment of patients with small-cell lung cancer].
    Chuchalin AG; Konovalov GA; Peredvodchikova NI; Kadagidze ZG; Gorbunova VA; Bobkov EV; Kozlov DV
    Ter Arkh; 1998; 70(3):52-6. PubMed ID: 9575590
    [No Abstract]   [Full Text] [Related]  

  • 24. Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions.
    Ray PK; McLaughlin D; Allen P; Bandyopadhyay S; Idiculla A; Clarke L; Mark R; Rhoads JE; Bassett JG; Cooper DR
    J Biol Response Mod; 1984; 3(3):293-302. PubMed ID: 6379112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity following protein A treatment of metastatic breast adenocarcinoma.
    Ainsworth SK; Pilia PA; Pepkowitz SH; O'Brien P
    Cancer; 1988 Apr; 61(8):1495-500. PubMed ID: 3349417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical response to protein a-treated plasma infusions and in vitro correlation.
    MacKintosh FR; Bennett K; Hall SW
    J Biol Response Mod; 1984; 3(3):336-40. PubMed ID: 6379117
    [No Abstract]   [Full Text] [Related]  

  • 27. Experience with Staphylococcus aureus and protein A in the treatment of canine malignancies.
    Bowles CA; Messerschmidt G; Deisseroth AB
    J Biol Response Mod; 1984; 3(3):260-5. PubMed ID: 6379110
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma therapy of primary rat mammary carcinoma: antitumor activity of tumor-bearer plasma adsorbed against inactivated CNBr sepharose or protein A-sepharose.
    Sukumar S; Zbar B; Terata N; Langone JJ
    J Biol Response Mod; 1984; 3(3):303-15. PubMed ID: 6379113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perfusion of plasma over Staphylococcus aureus: release of bacterial products is related to regression of tumor.
    Gordon BR; Matus RE; Hurvitz AI; MacEwen EG; Saal SD; Stenzel KH; Rubin AL; Hyden H
    J Biol Response Mod; 1984; 3(3):266-70. PubMed ID: 6379111
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase I trial of Staphylococcus aureus Cowan I immunoperfusion.
    Messerschmidt G; Bowles C; Dean D; Parker M; Lester R; Dowling R; Holohan T; Osborne L; Schaff BF; McCormack K; Corbitt R; Phillips T; Glatstein E; Deisseroth A
    Cancer Treat Rep; 1982 Dec; 66(12):2027-31. PubMed ID: 7139644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors.
    Peres E; Wood GW; Poulik J; Baynes R; Sood S; Abidi MH; Klein J; Bhambhani K; Dansey R; Abella E
    Neuropediatrics; 2008 Jun; 39(3):151-6. PubMed ID: 18991194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
    Uchida A; Kolb R; Micksche M
    J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor necrosis induced by ex vivo perfusion of the plasma of adenocarcinoma patients through columns of protein A].
    Kinet JP; Frankenne F; Hennen G; Balland N; Foidart J; Saint-Rémy M; Mahieu P
    Bull Mem Acad R Med Belg; 1983; 138(1):104-17. PubMed ID: 6882964
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumoricidal responses in spontaneous canine neoplasms after extracorporeal perfusion over immobilized protein A.
    Terman DS
    Fed Proc; 1981 Jan; 40(1):45-9. PubMed ID: 7450063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumoricidal response following perfusion over immobilized protein A: identification of immunoglobulin oligomers in serum after perfusion and their partial characterization.
    Balint J; Ikeda Y; Langone JJ; Shearer WT; Daskal I; Meek K; Cook G; Henry J; Terman DS
    Cancer Res; 1984 Feb; 44(2):734-43. PubMed ID: 6607106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of Protein-A in the treatment of malignancy: rationale and the NCI experience.
    Messerschmidt GL; Bowles C; Parrillo J; Parker M; Shelhammer J; Dowling R; Osborne L; Corbitt R; McCormack K; Longo D; Deisseroth A
    Prog Clin Biol Res; 1982; 106():385-90. PubMed ID: 6757952
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.
    Fisher DC; Sherrill GB; Hussein A; Rubin P; Vredenburgh JJ; Elkordy M; Ross M; Petros W; Peters WP
    Bone Marrow Transplant; 1996 Jul; 18(1):193-8. PubMed ID: 8832014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.
    Glantz MJ; Choy H; Akerley W; Kearns CM; Egorin MJ; Rhodes CH; Cole BF
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):128-35. PubMed ID: 9007140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
    Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
    Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.